<DOC>
	<DOCNO>NCT01466465</DOCNO>
	<brief_summary>Allergen-specific immunotherapy causal therapy Immunoglobulin E-induced allergy like allergic rhinoconjunctivitis . Despite progress last decade limit long treatment time high non-responder frequency . Based experimental epidemiological evidence hypothesize vitamin D act effective immunomodulatory adjuvant overcome limitation .</brief_summary>
	<brief_title>Vitamin D Grass Pollen Specific Immunotherapy</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>write informed consent relative Vitamin D deficiency clinical relevant grass pollen allergy positive intradermal test grass pollen force expiratory volume one second ( FEV1 ) &gt; 70 % current specific immunotherapy instable allergic asthma pregnancy lactation treatment immunomodulators immunosuppressive drug sarcoidosis , chronic disease , malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>SIT</keyword>
	<keyword>Grass pollen</keyword>
	<keyword>allergic rhinoconjunctivitis</keyword>
</DOC>